Two Roads Shared Trust - APEX HealthCare ETF (APXH) Stock Analysis
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Two Roads Shared Trust - APEX HealthCare ETF (APXH) trades at $8.87. Two Roads Shared Trust - APEX HealthCare ETF (APXH) is an exchange-traded fund focused on the financial services sector, specifically asset management. Sector: Financial services.
Price as of Aug 21, 2026 · Last analyzed: Mar 17, 2026Analyst Coverage for APXH: APXH does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates APXH against Financial Services peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.
APXH: 1/3 scored disciplines lean bearish. Dominant signal: Seth Klarman bearish.
How is this calculated? →Two Roads Shared Trust - APEX HealthCare ETF (APXH) Financial Services Profile
Two Roads Shared Trust - APEX HealthCare ETF operates within the asset management industry, offering investors a targeted approach to healthcare sector exposure. The ETF's performance is influenced by the broader financial markets and the specific dynamics of the healthcare industry, providing a diversified investment vehicle.
What Is the Investment Thesis for APXH?
The APEX HealthCare ETF presents a focused investment vehicle for those seeking exposure to the healthcare sector. With a beta of 0.75, the ETF exhibits lower volatility compared to the broader market, potentially offering a more stable investment option. Growth catalysts include ongoing advancements in medical technology and increasing demand for healthcare services due to an aging population. The ETF's value is driven by the performance of its underlying healthcare holdings, making it sensitive to factors such as regulatory changes and pharmaceutical pricing pressures. Investors may want to evaluate the ETF's expense ratio and tracking error relative to its benchmark index when evaluating its suitability for their portfolio. The ETF's diversification within the healthcare sector helps mitigate some company-specific risks, but it remains subject to broader market and sector-specific risks.
Based on FMP financials and quantitative analysis
APXH Key Highlights
The ETF provides targeted exposure to the healthcare sector, allowing investors to participate in the growth of this industry.
- The ETF's diversified holdings within the healthcare sector help mitigate company-specific risks.
- The ETF's beta of 0.75 indicates lower volatility compared to the broader market.
- The ETF offers a liquid and transparent investment vehicle for accessing the healthcare sector.
- The ETF's performance is influenced by factors such as healthcare policy changes, technological advancements, and demographic trends.
Who Are APXH's Competitors?
APXH is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| XLV State Street Health Care Select Sector SPDR ETF | $172.39 | -1.87% | $44.3B | 49 |
| IBB iShares Biotechnology ETF | $210.83 | -2.83% | $10.4B | 47 |
| XBI State Street SPDR S&P Biotech ETF | $163.79 | -3.40% | $8.56B | 47 |
| ABALX American Funds American Balanced Fund Class A | $41.00 | +0.37% | $292B | 72 |
| BX Blackstone Inc. | $141.41 | -2.54% | $171B | 81 |
| AMFCX American Funds American Mutual Fund | $63.80 | -0.72% | $77.4B | 71 |
| RNNEX American Funds The New Economy Fund Class R-2E | $80.46 | -0.29% | $52.9B | 91 |
| AMP Ameriprise Financial, Inc. | $554.06 | -1.02% | $49.8B | 70 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are APXH's Key Strengths?
Targeted exposure to the healthcare sector.
- Diversified holdings within the healthcare sector.
- Liquid and transparent investment vehicle.
- Lower volatility compared to the broader market (beta of 0.75).
What Are APXH's Weaknesses?
Subject to sector-specific risks, such as regulatory changes and pharmaceutical pricing pressures.
- Performance is dependent on the performance of its underlying healthcare holdings.
- May not outperform the broader market during periods of strong economic growth.
- Expense ratio can impact overall returns.
What Could Drive APXH Stock Higher?
Positive clinical trial results for key pharmaceutical companies within the ETF's holdings.
- Increasing demand for healthcare services due to an aging population.
- Technological advancements in medicine driving growth in the healthcare sector.
What Are the Key Risks for APXH?
Regulatory changes and healthcare policy reforms impacting the healthcare industry.
- Pharmaceutical pricing pressures and patent expirations affecting pharmaceutical companies.
- Economic downturns impacting healthcare spending.
- Competition from other healthcare-focused ETFs and mutual funds.
What Are the Growth Opportunities for APXH?
- Increased Healthcare Spending: The global healthcare expenditure is projected to continue its upward trajectory, driven by factors such as an aging population, rising prevalence of chronic diseases, and advancements in medical technology. This trend creates a favorable environment for healthcare companies and, consequently, for healthcare-focused ETFs like APXH. Timeline: Ongoing.
- Technological Advancements in Healthcare: Rapid advancements in medical technology, including areas such as gene therapy, precision medicine, and digital health, are transforming the healthcare landscape. These innovations are driving growth in the healthcare sector and creating new investment opportunities. APXH can benefit from investing in companies that are at the forefront of these technological advancements. Timeline: Ongoing.
- Expansion into Emerging Markets: Emerging markets are experiencing rapid economic growth and increasing access to healthcare services. This trend is creating new opportunities for healthcare companies to expand their operations and reach new customers. APXH can benefit from investing in healthcare companies that are expanding into emerging markets. The healthcare market in emerging economies is expected to grow at a faster pace than in developed countries. Timeline: Ongoing.
- Increased Focus on Preventive Care: There is a growing emphasis on preventive care and wellness programs as a means of reducing healthcare costs and improving health outcomes. This trend is creating new opportunities for companies that offer preventive care services and products. APXH can benefit from investing in companies that are focused on preventive care. The market for preventive care services is expected to grow significantly in the coming years. Timeline: Ongoing.
- Consolidation in the Healthcare Industry: The healthcare industry is undergoing a period of consolidation, with mergers and acquisitions occurring across various sub-sectors. This trend can create value for investors as companies become more efficient and gain greater market share. APXH can benefit from investing in companies that are involved in mergers and acquisitions. The value of healthcare mergers and acquisitions is expected to remain high in the coming years. Timeline: Ongoing.
What Are APXH's Competitive Advantages?
- Diversification: The ETF's diversified holdings within the healthcare sector help mitigate company-specific risks.
- Liquidity: The ETF offers a liquid and transparent investment vehicle for accessing the healthcare sector.
- Low Cost: ETFs generally have lower expense ratios compared to actively managed mutual funds.
What Does APXH Do?
Two Roads Shared Trust - APEX HealthCare ETF is designed to provide investors with targeted exposure to the healthcare sector through a diversified portfolio of healthcare-related companies. As an exchange-traded fund (ETF), it aims to track the performance of a specific healthcare index or benchmark, offering a convenient way for investors to participate in the growth of the healthcare industry. The ETF's holdings typically include companies involved in pharmaceuticals, biotechnology, medical devices, healthcare services, and other related areas. The fund operates under the Two Roads Shared Trust, an entity focused on creating and managing investment products. The APEX HealthCare ETF provides a liquid and transparent investment vehicle, allowing investors to easily buy and sell shares on major stock exchanges. The ETF's investment strategy involves selecting and weighting healthcare stocks to mirror the performance of its target index, providing diversification within the healthcare sector. The ETF's performance is influenced by factors such as healthcare policy changes, technological advancements in medicine, demographic trends, and overall economic conditions. The ETF offers a way to gain exposure to the healthcare sector's growth potential while managing risk through diversification.
What Products and Services Does APXH Offer?
- Provides investors with targeted exposure to the healthcare sector.
- Tracks the performance of a specific healthcare index or benchmark.
- Offers a diversified portfolio of healthcare-related companies.
- Invests in companies involved in pharmaceuticals, biotechnology, medical devices, and healthcare services.
- Provides a liquid and transparent investment vehicle for accessing the healthcare sector.
- Allows investors to easily buy and sell shares on major stock exchanges.
How Does APXH Make Money?
- The ETF generates revenue through management fees charged to investors.
- The ETF's performance is driven by the performance of its underlying healthcare holdings.
- The ETF aims to track the performance of its benchmark index, providing investors with a return that mirrors the healthcare sector's performance.
What Industry Does APXH Operate In?
The asset management industry is characterized by a diverse range of investment products, including ETFs, mutual funds, and hedge funds. The healthcare sector, in particular, has attracted significant investor interest due to its growth potential driven by aging populations and technological advancements. The APEX HealthCare ETF competes with other healthcare-focused ETFs and mutual funds, offering investors a specific investment strategy within this sector. The ETF's success depends on its ability to track its benchmark index and provide competitive returns relative to its peers. The industry is subject to regulatory oversight and market volatility, which can impact the performance of asset management firms and their investment products.
Who Are APXH's Key Customers?
- Individual investors seeking exposure to the healthcare sector.
- Institutional investors looking for a diversified healthcare investment vehicle.
- Financial advisors seeking to provide their clients with healthcare exposure.
Key Financial Metrics
Return on equity for Two Roads Shared Trust - APEX HealthCare ETF stands at 0.0%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is 0.0%, showing how much profit it generates from its asset base. APXH trades at a trailing price-to-earnings ratio of 0.00, below the Financial Services sector average of ~18x. Its free cash flow yield is 0.0%, a gauge of the cash the business throws off relative to its market value. A current ratio of 0.00 means current liabilities exceed short-term assets, a liquidity point worth watching. Its earnings yield is 0.0%, the inverse of the P/E and a quick read on earnings relative to price.
APXH Financials
Bull Case vs Bear Case
Bull Case
- Targeted exposure to the healthcare sector.
- Diversified holdings within the healthcare sector.
- Liquid and transparent investment vehicle.
- Lower volatility compared to the broader market (beta of 0.75).
Bear Case
- Subject to sector-specific risks, such as regulatory changes and pharmaceutical pricing pressures.
- Performance is dependent on the performance of its underlying healthcare holdings.
- May not outperform the broader market during periods of strong economic growth.
- Expense ratio can impact overall returns.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · August 2026
APXH Latest News
No recent news available for APXH.
APXH Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for APXH.
Price Targets
Wall Street price target analysis for APXH.
APXH MoonshotScore
What does this score mean?
The MoonshotScore rates APXH 0-100 on quantitative fundamentals — growth, financial health, valuation, momentum, and risk.
Two Roads Shared Trust - APEX HealthCare ETF Financial Services Stock: Key Questions Answered
What does Two Roads Shared Trust - APEX HealthCare ETF do?
Two Roads Shared Trust - APEX HealthCare ETF is an exchange-traded fund designed to provide investors with targeted exposure to the healthcare sector. It achieves this by investing in a diversified portfolio of companies involved in various aspects of healthcare, including pharmaceuticals, biotechnology, medical devices, and healthcare services.
What are the main risks for APXH?
The APEX HealthCare ETF is subject to several risks, including sector-specific risks such as regulatory changes and pharmaceutical pricing pressures. The ETF's performance is dependent on the performance of its underlying healthcare holdings, making it vulnerable to company-specific risks and market volatility. Economic downturns can impact healthcare spending, which could negatively affect the ETF's performance.
How does Two Roads Shared Trust - APEX HealthCare ETF make money in financial services?
Two Roads Shared Trust - APEX HealthCare ETF generates revenue primarily through management fees charged to investors. These fees are typically a percentage of the ETF's assets under management (AUM). The ETF's profitability is directly linked to its ability to attract and retain investors, as a larger AUM translates to higher management fee revenue.
What is Two Roads Shared Trust - APEX HealthCare ETF's credit quality and risk management approach?
As an ETF investing in publicly traded healthcare companies, Two Roads Shared Trust - APEX HealthCare ETF does not have a credit quality in the traditional sense of a lending institution. Its risk management focuses on diversification within the healthcare sector to mitigate company-specific risks.
What are the key factors to evaluate for APXH?
Evaluate APXH on fundamentals, analyst consensus, and risk factors. The APEX HealthCare ETF presents a focused investment vehicle for those seeking exposure to the healthcare sector. Not financial advice.
How frequently does APXH data refresh on this page?
APXH's price was last updated on Aug 21, 2026 and refreshes on page view during U.S. market hours — it is not a real-time exchange feed. Fundamentals update after quarterly filings; the MoonshotScore recalculates nightly; news aggregates continuously.
What has driven APXH's recent stock price performance?
Two Roads Shared Trust - APEX HealthCare ETF (APXH) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Targeted exposure to the healthcare sector. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider APXH overvalued or undervalued right now?
Two Roads Shared Trust - APEX HealthCare ETF (APXH) has no trailing P/E available here, so lean on price-to-sales and cash flow in the Financials tab. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- AI analysis is pending for APXH, limiting the depth of available insights.
- The ETF's performance is subject to market volatility and sector-specific risks.
- Investors should consult with a financial advisor before making any investment decisions.